Tom Rifai: Menopause as a Critical Window for Cardiometabolic Prevention
Tom Rifai, Founder and CEO at Reality Meets Science Inc., shared a post on LinkedIn about a recent article by Lily N. Dastmalchi et al. published in JACC:
“A new paper in JACC: Advances highlights menopause as an important cardiometabolic transition point in a woman’s life.
During the menopausal transition, changes in hormones, body fat distribution, lipids, insulin sensitivity, sleep, and vascular function can accelerate cardiovascular risk.
The key message is not criticism of clinicians.
Rather, it reflects how traditional training often separated women’s health, cardiology, and metabolic medicine into different silos.
Menopause should be recognized as a valuable window for prevention. It is an opportunity for clinicians to pay closer attention to cardiometabolic health and to strengthen lifestyle and risk factor management.
Better integration across primary care, cardiology, gynecology, and lifestyle medicine can help women navigate this transition with stronger long term cardiovascular health.
Reality Meets Science.
Midlife is not just a transition.
It is also an opportunity for prevention.”
Title: Improving Cardiovascular Clinical Competencies for the Menopausal Transition
Authors: Lily N. Dastmalchi, Martha Gulati, Rebecca C. Thurston, Emily Lau, Amy Sarma, Cherie Q. Marfori, Allison E. Gaffey, Stephanie Faubion, Deepika Laddu, Chrisandra L. Shufelt, Garima Sharma
Read the Full Article on JACC

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 18, 2026, 15:11Vansh Yaduvanshi: Why Compatible Blood Groups Do Not Always Mean Compatible Blood
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: The Ecological Transition in Thrombosis and Haemostasis